Suppr超能文献

外周动脉闭塞性疾病患者血小板存活时间测量的可重复性

Reproducibility of platelet survival time measurements in patients with peripheral arterial occlusive disease.

作者信息

Minar E, Ehringer H

机构信息

Department of Angiology, I. Medical University Clinic, Vienna, Austria.

出版信息

Thromb Res. 1987 Oct 1;48(1):73-9. doi: 10.1016/0049-3848(87)90347-1.

Abstract

In this study we investigated the reproducibility of 111-In-platelet survival time (PST) measurements and of plasma levels of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in 30 patients (median age: 60.5 years) with arteriographically proven peripheral arterial occlusive disease (PAOD) in a chronic stable phase. PST calculated by both the weighted mean - WM - (1. investigation: 187.1 [median] hours - repeat investigation: 188.3 hours) and multiple hit - MH - model (181.4----177.4 hours) demonstrated only a small spontaneous variation. The median coefficient of variation (CV) was 3.0 (WM) and 3.2 (MH), respectively. The reproducibility of beta-TG (CV: 6.1) was also satisfactory. We conclude that the good reproducibility of PST and plasma levels of beta-TG make them well suited to judge the influence of platelet-suppressant drugs on these parameters in patients with PAOD.

摘要

在本研究中,我们调查了30例(中位年龄:60.5岁)经血管造影证实处于慢性稳定期的外周动脉闭塞性疾病(PAOD)患者中,¹¹¹铟标记血小板存活时间(PST)测量值以及β-血小板球蛋白(β-TG)和血小板因子4(PF 4)血浆水平的可重复性。通过加权均值 - WM - (首次测量:187.1[中位数]小时 - 重复测量:188.3小时)和多次打击 - MH - 模型(181.4----177.4小时)计算得出的PST仅显示出较小的自发变化。变异系数(CV)中位数分别为3.0(WM)和3.2(MH)。β-TG的可重复性(CV:6.1)也令人满意。我们得出结论,PST和β-TG血浆水平的良好可重复性使其非常适合用于判断血小板抑制药物对PAOD患者这些参数的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验